Ready to Improve Your Biomarker Intelligence?

TALK TO A BIOMARKER STRATEGIST

Chart of the Week: 3x Improvement in Likelihood of Approval

by

In May we released a report co-authored with BIO and BioMedTracker. One of the key take-aways from the report is that patient selection biomarkers, if used successfully, can triple the Likelihood of Approval (LOA) for clinical studies.  Here is the data:

Biomarker_triple_clinical_trial_success_rates.png

Share this Image On Your Site

Please include attribution to amplion.com with this graphic.

3x Improvements in Clinical Trial Likelihood of Approval

To learn more about Amplion and BiomarkerBase:

REQUEST A MEETING